Dawn Svoronos
Board Member
Xenon Pharmaceuticals Inc. (XENE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dawn Svoronos
Dawn Svoronos is recorded as Board Member at Xenon Pharmaceuticals Inc. (XENE). Xenon Pharmaceuticals Inc. reported in an 8-K filed June 3, 2026 that Dawn Svoronos was appointed directors, effective June 2, 2026.
“The following nominees were elected as directors to serve until the 2027 annual meeting of shareholders or until their respective successors are duly elected and qualified: | | For | Against | | BrokerNon-Votes | | | --- | --- | --- | --- | --- | --- | | Dawn Svoronos | 82,475,281.53 | | 4,517,221.65 | | 3,407,133.11”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Xenon Pharmaceuticals Inc.
Other people whose current roles at this company are on record from its filings.
- Ian Mortimer CEO, Chief Accounting Officer, Board Member
- Simon Pimstone Chairman
- Thomas (Tucker) Kelly CFO
- Thomas Kelly CFO
- Tucker Kelly CFO
- Clarissa Desjardins Board Member
- Dr. Clarissa Desjardins Board Member
- Dr. Gillian Cannon Board Member
- Elizabeth Garofalo Board Member
- Frank Holler Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.